| Sign In to gain access to subscriptions and/or personal tools. |
Morphine hyperalgesia: A case reportDepartment of Community Health and Family Medicine, University of Florida Health Science Center, Jacksonville, Florida, Charles M. Neviaser Educational Institute, Community Hospice Northeast Florida, Jacksonville, Florida
Division of Palliative Medicine, Department of Community Health and Family Medicine, University of Florida Health Science Center, Jacksonville, Florida We report a case of a patient with metastatic testicular cancer and intractable pain refractory to massive doses of oral, intravenous, and intrathecal (IT) opioids supported by analgesic adjuvants. During our efforts to control his pain, the patient exhibited opioid-induced hyperalgesia, an uncommon but important phenomenon seen with high-dose opioid therapy. With appropriate opioid adjustmentin this case reduction of intrathecal morphine dosage by a factor of 100the condition rapidly resolved and the patient became pain-free and remained so until his death six weeks later. The keys to identifying this uncommon, but treatable, opioid side effect are recognizing it as a possibility when aggressive efforts to control pain with high doses of opioids, especially when administered neuraxially, are met with increasing pain.
Key Words: cancer analgesia hyperalgesia pain opioid
American Journal of Hospice and Palliative Medicine®, Vol. 20, No. 6,
459-461 (2003) This article has been cited by other articles:
|
|||||||||||||||
